| Typicality: | 0.606 |
| Saliency: | 0.607 |
| by administering qidssr16 | 3 | manner |
| usually | 2 | temporal |
| before starting the antiviral therapy | 2 | temporal |
| depression → be → assessed | 55 |
| depression → be → evaluated | 14 |
| depression → be → examined | 4 |
| negative | neutral | positive |
| 0.405 | 0.561 | 0.034 |
| Raw frequency | 73 |
| Normalized frequency | 0.607 |
| Modifier score | 0.800 |
| Perplexity | 184.111 |